Chesapeake Biotech Partners is an oncology & hematology consulting company that was formed to help companies bridge the gap between scientific innovation and marketing success. Our total immersion in the science of cancer enhances our senior consultants' many years of cross-functional industry experience focused in oncology. A clinical development strategy that is fully integrated with the commercialization plan is the key to a successful launch. We have a deep understanding and extraordinary insight into the unique drivers of the oncology market. This gives you the edge with life-cycle management -- ranging from planning your clinical trial programs, to pre-launch activities, through positioning for post-marketing label expansion opportunities. Plans need execution -- and we have the training and education programs to help your MSL and sales teams successfully launch your therapeutic or supportive care product. We design and deliver product and tumor-specific training. We also offer professional development programs that enhance the skills of your key field-based staff so they are better equipped for peer-to-peer scientific dialogue and discussion with their customers. Oncology strategy is our expertise! Let Chesapeake's senior oncology consultants guide the development of your novel therapeutic to commercial success -- as only then will patients with cancer have the chance for the cure that we all hope for.